Aegon Ltd. vs Cerebras Systems Inc. — how do they compare? Aegon Ltd. trades at $9.13 (market cap $13.42B), while Cerebras Systems Inc. trades at $209.77 (market cap $47.13B). The key difference: Cerebras Systems Inc. is far larger — about 3.5× Aegon Ltd.'s market cap, and Aegon Ltd. pays a 5.37% dividend while Cerebras Systems Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Aegon Ltd. for 45 Days and Cerebras Systems Inc. for 1 Days on average.
| AEG | CBRS | |
|---|---|---|
Market Cap | $13.42B | $47.13B |
Volume | 2,611,190 | 10,804,205 |
Sector | Financials | Technology |
52-Week High | $9.53 | $311.07 |
52-Week Low | $6.79 | $168.52 |
Typical Hold Time | 45 Days | 1 Days |
Enterprise Value | $13.78B | $40.69B |
Dividend Yield | 5.37% | — |
Signals from Pluang's Aura AI — not financial advice
AEG trades at $9.125, up 0.94% daily, with a bearish technical signal but improving fundamentals. Recent earnings show mixed beats, with Q4 2025 missing estimates, while 2025 revenue reached $26.86 billion and net income $977 million. The company maintains a strong gross margin of 82.52% and a P/E of 12.13, indicating reasonable valuation. News highlights strategic moves like vertiport development and buyback expansions, signaling growth initiatives.
Outlook is cautiously optimistic due to solid profitability and strategic expansions, but risks include volatile cash flows and a high debt-to-asset ratio. Analyst consensus is mixed with 27.78% buy ratings, reflecting uncertainty amid operational execution challenges and macroeconomic pressures.
CBRS trades at $198.37, up 2.18% with neutral technical signals. The company shows strong revenue growth ($510M in 2025, $681M projected for 2026) but faces profitability challenges with negative net margins (-75.27%) and ROE (-11.6%). Recent news highlights expansion into AI inference infrastructure and a massive $25.4 billion backlog, including a major OpenAI agreement. Technical indicators show the stock trading near resistance at $198 with support at $191.
Despite profitability concerns, CBRS maintains strong analyst support (87.5% buy ratings) with a $300.50 consensus target representing 51% upside. Key risks include customer concentration, margin pressure, and intense AI infrastructure competition. The substantial backlog and capacity expansion provide growth catalysts, but investors should weigh high valuation multiples against ongoing losses.
Trailing returns across standard periods
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →Cerebras develops AI computing systems built around its Wafer-Scale Engine processor. Its systems are available in the cloud and on premises for training, fine-tuning, and running AI models.
Read more on CBRS →